Journal of Immunology Research

Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies


Publishing date
01 Sep 2018
Status
Published
Submission deadline
27 Apr 2018

Lead Editor

1University of Münster, Münster, Germany

2Southwest Medical University, Luzhou, China

3Navy General Hospital, Beijing, China


Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies

Description

In the last decade, immunotherapies methods have been playing a key role in the clinical treatment of cancer. It has been clearly demonstrated that the characteristics of different cancers were the basement for the specific cancer immunotherapies. Cancer cell can be attacked by immune system targeting tumor-associated antigens via active immunotherapy; moreover, antitumor responses can also be enhanced by using antibodies, lymphocytes, or cytokines via passive immunotherapies. The competence of immunotherapies, however, is largely dependent on the properties of immune response in the tumor microenvironment. Therefore, a thorough understanding of above process will help us find more effective cancer immunotherapies strategies.

The high-quality original research articles as well as review articles are invited to understand and clarify the related fundamental knowledge and underlying mechanism of immune response during the respective cancer immunotherapies process so as to explore more new therapeutic strategies and improve the clinical efficiency on cancer treatment.

Potential topics include but are not limited to the following:

  • Alteration of immune cell properties in cancer development
  • Immunomodulation of the tumor microenvironment by immunotherapy
  • Exploration of cancer immunotherapy targets
  • Combining immunotherapy and targeted therapies in cancer treatment
  • Pharmacological strategies for cancer immunotherapy

Articles

  • Special Issue
  • - Volume 2019
  • - Article ID 1513964
  • - Editorial

Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies

Jian Song | Zenghui Teng | Weidong Cao
  • Special Issue
  • - Volume 2019
  • - Article ID 3628956
  • - Research Article

Alterations of Hematologic and Hematopoietic Parameters in Mice Exposed to Pulsed Electromagnetic Field

Kangchu Li | Zenghui Teng | ... | Shirong Ma
  • Special Issue
  • - Volume 2019
  • - Article ID 9561350
  • - Research Article

Neutrophil-Derived MRP14 Supports Plasma Cell Commitment and Protects Myeloma Cells from Apoptosis

Zhihong Zhao | Zhonghua Luo | ... | Weidong Cao
  • Special Issue
  • - Volume 2018
  • - Article ID 5804230
  • - Research Article

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types

Marcella Tazzari | Silvia Brich | ... | Chiara Castelli
  • Special Issue
  • - Volume 2018
  • - Article ID 2984247
  • - Review Article

Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

Marco Antonio Hernández-Luna | Rosendo Luria-Pérez
  • Special Issue
  • - Volume 2018
  • - Article ID 7498514
  • - Research Article

miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells

Yong Li | Ping Gong | ... | Na Li
  • Special Issue
  • - Volume 2018
  • - Article ID 1687097
  • - Research Article

Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A

Dan Luo | Zheng Zhang | ... | Zi-Ling Wang
  • Special Issue
  • - Volume 2018
  • - Article ID 5690258
  • - Research Article

Expression of PD-1 on CD4+ Tumor-Infiltrating Lymphocytes in Tumor Microenvironment Associated with Pathological Characteristics of Breast Cancer

Yan-Jie Zhao | Jian Zhang | ... | Qing-Kun Song
  • Special Issue
  • - Volume 2018
  • - Article ID 7646913
  • - Review Article

Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials

Yanhua Zheng | Hongyuan Shen | ... | Guangxun Gao
  • Special Issue
  • - Volume 2018
  • - Article ID 4180517
  • - Research Article

PD-L1 Expression and CD8+ T Cell Infiltration Predict a Favorable Prognosis in Advanced Gastric Cancer

Yangyang Wang | Chunchao Zhu | ... | Hui Cao
Journal of Immunology Research
 Journal metrics
Acceptance rate40%
Submission to final decision65 days
Acceptance to publication30 days
CiteScore3.330
Impact Factor3.404
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.